David Haigh

3.9k citations

53 papers · 3.1k · 1 hit paper · h-index 28

Impact in

Organic Chemistry top 2%
- Cyclopropane Reaction Mechanisms
- Catalytic C–H Functionalization Methods
- Asymmetric Synthesis and Catalysis
Molecular Biology top 5%
- Peroxisome Proliferator-Activated Receptors
- Wnt/β-catenin signaling in development and cancer
- Chemical Synthesis and Analysis
- Metabolism, Diabetes, and Cancer

Papers in

Organic Chemistry 28
- Cyclopropane Reaction Mechanisms 9
- Catalytic C–H Functionalization Methods 6
- Carbohydrate Chemistry and Synthesis 5
- Synthesis and Catalytic Reactions 5
Molecular Biology 25
- Peroxisome Proliferator-Activated Receptors 6
- Chemical Synthesis and Analysis 5

Co-authors: Richard M. Hindley (10 shared papers)David G. Smith (7 shared papers)Barrie C. C. Cantello (10 shared papers)Robert W. Ward (5 shared papers)Julie C. Holder (4 shared papers)Stephen A. Smith (6 shared papers)Gregory Murphy (3 shared papers)Christopher J. Moody (8 shared papers)
Journals: Journal of the Chemical Society Perkin Transactions 1 (8 papers)Bioorganic & Medicinal Chemistry Letters (7 papers)Tetrahedron Letters (5 papers)Tetrahedron Asymmetry (4 papers)Tetrahedron (3 papers)
Partner nations: United Kingdom Australia United States

In The Last Decade

David Haigh

53 papers receiving 3.0k citations

David Haigh's Hit Papers

align trajectories log scale

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription 2000 · 780 citations

Peers

Countries citing papers authored by David Haigh

Since Specialization

Citations

This map shows the geographic impact of David Haigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Haigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Haigh more than expected).

Fields of papers citing papers by David Haigh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Haigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Haigh. The network helps show where David Haigh may publish in the future.

Co-authors

The 25 scholars most cited alongside David Haigh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Haigh Line = papers co-authored together David Haigh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription Chemistry & Biology ·Matthew P. Coghlan, Ainsley A. Culbert, Darren A.E. Cross, Stacey L. Corcoran, John Yates, (unknown), Oliver Rausch, Gregory Murphy, Paul S. Carter, Lynne Roxbee Cox, David Mills, Murray J. B. Brown, David Haigh, Robert W. Ward, David G. Smith, Kenneth Murray, Alastair D. Reith, Julie C. Holder Hit paper breakdown →	2000	780
2	[[.omega.-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents Journal of Medicinal Chemistry ·Barrie C. C. Cantello, Michael A. Cawthorne, Graham P. Cottam, Peter T. Duff, David Haigh, Richard M. Hindley, Carolyn A. Lister, Stephen A. Smith, P. L. Thurlby	1994	230
3	Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma. PubMed ·Paul Young, Derek R. Buckle, Barrie C. C. Cantello, Helen Chapman, John C. Clapham, Paul J. Coyle, David Haigh, Richard M. Hindley, Julie C. Holder, Howard Kallender, Alison J. Latter, K. W. M. Lawrie, Danuta E. Mossakowska, Gregory Murphy, Lynne Roxbee Cox, Stephen A. Smith	1998	207
4	3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3) Bioorganic & Medicinal Chemistry Letters ·David G. Smith, Marianne Buffet, Ashley Fenwick, David Haigh, Robert J. Ife, Martin Saunders, Brian P. Slingsby, Rachel Stacey, Robert W. Ward	2001	147
5	Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. BMJ ·H. J. Bodansky, Anthony Staines, C. R. Stephenson, David Haigh, R. Cartwright	1992	139
6	Remote Chiral Induction in the Organocatalytic Hydrosilylation of Aromatic Ketones and Ketimines Angewandte Chemie International Edition ·Andrei V. Malkov, Angus J. P. Stewart Liddon, Pedro Ramírez‐López, Lada Bendová, David Haigh, Pavel Kočovský	2006	120
7	5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3) Bioorganic & Medicinal Chemistry Letters ·Jason Witherington, Vincent Bordas, David Haigh, Deirdre M. B. Hickey, Robert J. Ife, Anthony D. Rawlings, Brian P. Slingsby, David G. Smith, Robert W. Ward	2003	98
8	The synthesis of BRL 49653 - a novel and potent antihyperglycaemic agent Bioorganic & Medicinal Chemistry Letters ·Barrie C. C. Cantello, Michael A. Cawthorne, David Haigh, Richard M. Hindley, Stephen A. Smith, P. L. Thurlby	1994	96
9	Identification of High-Affinity Binding Sites for the Insulin Sensitizer Rosiglitazone (BRL-49653) in Rodent and Human Adipocytes Using a Radioiodinated Ligand for Peroxisomal Proliferator-Activated Receptor γ Journal of Pharmacology and Experimental Therapeutics ·Paul Young, Derek R. Buckle, Barrie C. C. Cantello, Helen Chapman, John C. Clapham, Paul J. Coyle, David Haigh, Richard M. Hindley, Julie C. Holder, Howard Kallender, Alison J. Latter, K. W. M. Lawrie, Danuta E. Mossakowska, Gregory Murphy, Lynne Roxbee Cox, Stephen A. Smith	1998	90
10	Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis Cell Death and Differentiation ·Emma Kerr, Caitriona Holohan, Kirsty M. McLaughlin, Joanna Majkut, Sarah Dolan, Kelly M. Redmond, Joel S. Riley, Izabela Stasik, Maelíosa T. C. Mc Crudden, Sandra Van Schaeybroeck, Cathy Fenning, Rosemary O’Connor, Patrick Kiely, Miriam Sgobba, David Haigh, Pace Johnston, Daniel B. Longley	2012	86
11	Differential affinity of FLIP and procaspase 8 for FADD’s DED binding surfaces regulates DISC assembly Nature Communications ·Joanna Majkut, Miriam Sgobba, Caitriona Holohan, Nyree Crawford, A. Logan, Emma Kerr, Catherine Higgins, Keara L. Redmond, Joel S. Riley, Izabela Stasik, Dean A. Fennell, Sandra Van Schaeybroeck, Shozeb Haider, Patrick G. Johnston, David Haigh, Daniel B. Longley	2014	66
12	Asymmetric rhodium carbenoid insertion into the SiH bond Tetrahedron Letters ·Richard T. Buck, Michael P. Doyle, (unknown), Leigh Ferris, David C. Forbes, David Haigh, Christopher J. Moody, Neil D. Pearson, Qi‐Lin Zhou	1996	64
13	N–H insertion reactions of rhodium carbenoids. Part 1. Preparation of α-amino acid and α-aminophosphonic acid derivatives Journal of the Chemical Society Perkin Transactions 1 ·Enrique Aller, Richard T. Buck, (unknown), Leigh Ferris, David Haigh, Christopher J. Moody, Neil D. Pearson, J. Bobby Sanghera	1996	56
14	Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies Oncotarget ·Shahin Assefnia, Sivanesan Dakshanamurthy, Jaime M. Guidry Auvil, Constanze Hampel, Panos Z. Anastasiadis, Bhaskar Kallakury, Aykut Üren, David Foley, Milton L. Brown, Lawrence Shapiro, Michael B. Brenner, David Haigh, Stephen W. Byers	2013	53
15	Trends in the incidence of childhood diabetes in south Asians and other children in Bradford, UK Diabetic Medicine ·Richard Feltbower, H. J. Bodansky, P A McKinney, John Houghton, C. R. Stephenson, David Haigh	2002	45
16	New pinene-derived pyridines as bidentate chiral ligands Tetrahedron ·Andrei V. Malkov, A.J.P. Stewart-Liddon, Filip Teplý, Lukáš Kobr, Kenneth W. Muir, David Haigh, Pavel Kočovský	2008	44
17	Asymmetric Synthesis of anN-Acylpyrrolidine for Inhibition of HCV Polymerase The Journal of Organic Chemistry ·Armel A. Agbodjan, Bob E. Cooley, Royston C. B. Copley, John Corfield, Roy C. Flanagan, Bobby Glover, Rossella Guidetti, David Haigh, Peter D. Howes, Mary M. Jackson, Richard T. Matsuoka, Katrina J. Medhurst, Alan Millar, Matthew J. Sharp, Martin J. Slater, Jennifer F. Toczko, Shiping Xie	2008	41
18	New members of the chiral pool: β-Hydroxypiperidine carboxylates from Baker's yeast reductions of the corresponding keto-esters Tetrahedron Asymmetry ·David W. Knight, Neil J. Lewis, Andrew C. Share, David Haigh	1993	41
19	Non thiazolidinedione antihyperglycaemic agents. 1: α-Heteroatom substituted β-phenylpropanoic acids Bioorganic & Medicinal Chemistry Letters ·Derek R. Buckle, Barrie C. C. Cantello, Michael A. Cawthorne, Paul J. Coyle, David K. Dean, Andrew Faller, David Haigh, Richard M. Hindley, L. J. JEFCOTT, Carolyn A. Lister, Ivan L. Pinto, Harshad K. Rami, David G. Smith, Stephen A. Smith	1996	40
20	Asymmetric rhodium carbene insertion into the SiH bond: identification of new dirhodium(II) carboxylate catalysts using parallel synthesis techniques Tetrahedron Asymmetry ·Richard T. Buck, Diane M. Coe, (unknown), Leigh Ferris, David Haigh, Christopher J. Moody, Neil D. Pearson, J. Bobby Sanghera	2003	36

About David Haigh

David Haigh is a scholar working on Organic Chemistry, Molecular Biology, Inorganic Chemistry, Pharmaceutical Science and Endocrinology, Diabetes and Metabolism, having authored 53 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cyclopropane Reaction Mechanisms (9 papers), Asymmetric Hydrogenation and Catalysis (6 papers), Peroxisome Proliferator-Activated Receptors (6 papers), Catalytic C–H Functionalization Methods (6 papers), Carbohydrate Chemistry and Synthesis (5 papers), Fluorine in Organic Chemistry (5 papers), Chemical Synthesis and Analysis (5 papers) and Synthesis and Catalytic Reactions (5 papers). The work is most often cited by research in Organic Chemistry (1.1k citations), Molecular Biology (1.7k citations), Biochemistry (147 citations), Inorganic Chemistry (233 citations) and Pharmacology (230 citations). David Haigh has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Richard M. Hindley, David G. Smith, Barrie C. C. Cantello, Robert W. Ward, Julie C. Holder, Stephen A. Smith, Gregory Murphy, Christopher J. Moody, Leigh Ferris and Michael A. Cawthorne. Their work appears in journals such as Journal of the Chemical Society Perkin Transactions 1, Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Tetrahedron Asymmetry and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

David Haigh

Impact in

Papers in i

In The Last Decade

David Haigh

David Haigh's Hit Papers

Peers

Countries citing papers authored by David Haigh

Fields of papers citing papers by David Haigh

All Works

About David Haigh

Explore authors with similar magnitude of impact

Papers in